Los Angeles Capital Management LLC Anavex Life Sciences Corp. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$3.39 - $5.02 $223,245 - $330,587	-65,854 Reduced 74.89%	22,077 $93,000
Q1 2024 Apr 05, 2024	BUY	$4.55 - $6.75 $135,790 - $201,447	29,844 Added 51.38%	87,931 $447,000
Q4 2023 Feb 06, 2024	BUY	$5.04 - $9.95 $190,849 - $376,776	37,867 Added 187.27%	58,087 $540,000
Q3 2023 Nov 06, 2023	BUY	$6.55 - $9.37 $132,441 - $189,461	20,220 New	20,220 $132,000
Q3 2022 Nov 02, 2022	BUY	$8.9 - $12.86 $129,931 - $187,743	14,599 New	14,599 $151,000

164

27.5M

515K

838K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $723M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.